Healthcare provider profile · identity verified

Jasbir Singh, M.D.

Family Practice · TURLOCK, CA · NPI 1366974685

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	772	221
Amlodipine Besylate	Amlodipine Besylate	436	137
Levothyroxine Sodium	Levothyroxine Sodium	390	106
Omeprazole	Omeprazole	334	96
Losartan Potassium	Losartan Potassium	316	97
Gabapentin	Gabapentin	291	79
Lisinopril	Lisinopril	257	76
Metformin Hcl	Metformin Hcl	244	71
Tamsulosin Hcl	Tamsulosin Hcl	232	65
Furosemide	Furosemide	188	54
Rosuvastatin Calcium	Rosuvastatin Calcium	186	57
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	175	55
Metoprolol Succinate	Metoprolol Succinate	153	50
Pantoprazole Sodium	Pantoprazole Sodium	147	41
Fluticasone Propionate	Fluticasone Propionate	144	62
Escitalopram Oxalate	Escitalopram Oxalate	140	41
Simvastatin	Simvastatin	138	41
Albuterol Sulfate Hfa	Albuterol Sulfate	134	47
Trazodone Hcl	Trazodone Hcl	128	47
Carvedilol	Carvedilol	125	33
Famotidine	Famotidine	122	32
Potassium Chloride	Potassium Chloride	114	34
Citalopram Hbr	Citalopram Hydrobromide	109	29
Metformin Hcl Er	Metformin Hcl	109	32
Eliquis	Apixaban	104	18
Montelukast Sodium	Montelukast Sodium	102	33
Metoprolol Tartrate	Metoprolol Tartrate	98	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	89	27
Duloxetine Hcl	Duloxetine Hcl	88	17
Tramadol Hcl	Tramadol Hcl	79	24
Zolpidem Tartrate	Zolpidem Tartrate	79	15
Sertraline Hcl	Sertraline Hcl	78	22
Hydrochlorothiazide	Hydrochlorothiazide	73	26
Pravastatin Sodium	Pravastatin Sodium	71	23
Terazosin Hcl	Terazosin Hcl	69	15
Clopidogrel	Clopidogrel Bisulfate	68	18
Tizanidine Hcl	Tizanidine Hcl	62	30
Atenolol	Atenolol	60	11
Azithromycin	Azithromycin	55	50
Bupropion Xl	Bupropion Hcl	55	11
Nifedipine Er	Nifedipine	55	17
Jardiance	Empagliflozin	54	15
Ezetimibe	Ezetimibe	52	19
Hydralazine Hcl	Hydralazine Hcl	52	14
Glipizide Er	Glipizide	51	15
Baclofen	Baclofen	49	suppressed
Finasteride	Finasteride	47	12
Mirtazapine	Mirtazapine	47	12
Alprazolam	Alprazolam	46	24
Meclizine Hcl	Meclizine Hcl	46	16
Allopurinol	Allopurinol	42	12
Fluoxetine Hcl	Fluoxetine Hcl	42	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	39
Glimepiride	Glimepiride	41	15
Naproxen	Naproxen	41	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Pregabalin	Pregabalin	37	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	32
Januvia	Sitagliptin Phosphate	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Hydrocortisone	Hydrocortisone	35	14
Alendronate Sodium	Alendronate Sodium	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	11
Nortriptyline Hcl	Nortriptyline Hcl	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	11
Xarelto	Rivaroxaban	33	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	32	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Ketoconazole	Ketoconazole	30	11
Ozempic	Semaglutide	30	suppressed
Lovastatin	Lovastatin	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Glipizide	Glipizide	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Klor-Con M20	Potassium Chloride	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Cephalexin	Cephalexin	23	20
Ibuprofen	Ibuprofen	23	16
Hydroxyzine Hcl	Hydroxyzine Hcl	22	11
Meloxicam	Meloxicam	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Lactulose	Lactulose	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Prednisone	Prednisone	20	19
Clonazepam	Clonazepam	19	suppressed
Digoxin	Digoxin	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Nitroglycerin	Nitroglycerin	18	15
Benazepril Hcl	Benazepril Hcl	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Linzess	Linaclotide	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Ondansetron Odt	Ondansetron	15	12
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Estradiol	Estradiol	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Movantik	Naloxegol Oxalate	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	13	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Diazepam	Diazepam	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	11
Dutasteride	Dutasteride	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Levofloxacin	Levofloxacin	11	11
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error